GW Pharmaceuticals plc GWPH

GW Pharmaceuticals plc DIO | GWPH

DIO Jährlich GW Pharmaceuticals plc

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.26 K	1.15 K	1.16 K	437	570	663	846	1.33 K	-	-

Alle Zahlen in USD-Währung

Höchstwert	Mindestwert	Durchschnitt
1.33 K	437	927

Name	DIO	Preis	% 24h	Marktkapitalisierung	Land
Kadmon Holdings, Inc. KDMN	18.6	-	-	$ 1.7 B	USA
Liminal BioSciences LMNL	1.68 K	-	-	$ 256 M	Canada
Neos Therapeutics, Inc. NEOS	160	-	-2.54 %	$ 57.2 M	USA
Osmotica Pharmaceuticals plc OSMT	87.9	-	-10.74 %	$ 89.9 M	USA
Viridian Therapeutics VRDN	18	$ 31.22	1.17 %	$ 3.18 B	USA
Zogenix, Inc. ZGNX	691	-	-4.97 %	$ 664 M	USA
Vanda Pharmaceuticals VNDA	50.1	$ 4.17	2.08 %	$ 246 M	USA
Verrica Pharmaceuticals VRCA	245	$ 3.88	10.23 %	$ 41.3 M	USA
ADMA Biologics ADMA	316	$ 13.19	4.1 %	$ 3.14 B	USA
Halozyme Therapeutics HALO	254	$ 101.68	-1.26 %	$ 12.2 B	USA
Hutchison China MediTech Limited HCM	49.7	$ 15.09	-1.92 %	$ 13 B	China
Aptorum Group Limited APM	12	-	-	$ 5.72 M	China
iBio IBIO	3.32 K	$ 0.82	5.55 %	$ 85.3 M	USA
Karyopharm Therapeutics KPTI	52.5	$ 0.02	-56.5 %	$ 219	USA
FSD Pharma HUGE	174	-	5743.5 %	$ 69.7 M	Canada
Catalyst Pharmaceuticals CPRX	119	-	-	$ 3.85 B	USA
UroGen Pharma Ltd. URGN	377	$ 26.14	3.24 %	$ 1.26 B	Israel
Catalyst Biosciences CBIO	214	$ 14.79	6.25 %	$ 1.32 B	USA
Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
ADiTx Therapeutics ADTX	1.06 K	-	-	$ 374	USA
Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada